✦ LIBER ✦

Targeting survivin in cancer therapy

✍ Scribed by Pennati, Marzia; Folini, Marco; Zaffaroni, Nadia

Book ID: 111865384
Publisher: Informa plc
Year: 2008
Tongue: English
Weight: 504 KB
Volume: 12
Category: Article
ISSN: 1472-8222
DOI: 10.1517/14728222.12.4.463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apoptosome Volume 890 || Targeting Survi

Apoptosome Volume 890 || Targeting Survivin in Cancer Therapy: Clinical Considerations

✍ Cecconi, Francesco; D'Amelio, Marcello 📂 Article 📅 2009 🏛 Springer Netherlands ⚖ 542 KB

Apoptosome Volume 890 || Targeting Survi

Apoptosome Volume 890 || Targeting Survivin in Cancer Therapy: Pre-clinical Studies

✍ Cecconi, Francesco; D'Amelio, Marcello 📂 Article 📅 2009 🏛 Springer Netherlands ⚖ 638 KB

Targeting survivin in leukemia

✍ Bing Z. Carter; Michael Andreeff 📂 Article 📅 2008 🏛 PAGEPress Publications 🌐 English ⚖ 216 KB

Targeting Histone Deacetylase in Cancer

Targeting Histone Deacetylase in Cancer Therapy

✍ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Targeting histone deacetylase in cancer

Targeting histone deacetylase in cancer therapy

✍ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB

## Abstract Histone deacetylase (HDAC) is recognized as one of the promising targets for cancer treatment as many HDAC inhibitors have entered clinical trials for both solid and liquid tumors. Nevertheless, the mechanisms underlying the antiproliferative effects of HDAC inhibitors remain elusive. A

Targeted cancer therapies

✍ Aggarwal, Saurabh 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 256 KB